Contineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Rating of "Moderate Buy" from Brokerages
Contineum Therapeutics, Inc. (NASDAQ:CTNM - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has issued a hold rec...